Levonorgestrel And Ethinyl Estradiol Kit
NDC Package 42192-623-28
Package Information
Levonorgestrel And Ethinyl Estradiol kits is levonorgestrel and ethinyl estradiol tablets, USP and ferrous bisglycinate tablets are indicated for use by females of reproductive potential to prevent pregnancy. This formulation utilizes a kit delivery system. Marketed by Acella Pharmaceuticals, this product is identified by NDC 42192-623 and is authorized under FDA application NDA208612.
Identification & Billing
- RxCUI: 242297 - levonorgestrel 0.1 MG / ethinyl estradiol 0.02 MG Oral Tablet
- RxCUI: 242297 - ethinyl estradiol 0.02 MG / levonorgestrel 0.1 MG Oral Tablet
- RxCUI: 2672922 - ferrous bisglycinate 36.5 MG Oral Tablet
- RxCUI: 2672923 - {21 (ethinyl estradiol 0.02 MG / levonorgestrel 0.1 MG Oral Tablet) / 7 (ferrous bisglycinate 36.5 MG Oral Tablet) } Pack
- RxCUI: 2672923 - Eth estra-Levonorgest 0.02-0.1 MG (21) Oral Tablet / ferrous bisglycinate 36.5 MG (7) Oral Tablet 28 Day Pack
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 42192 - Acella Pharmaceuticals
- 42192-623 - Levonorgestrel And Ethinyl Estradiol
- 42192-623-28 - 1 BLISTER PACK in 1 CARTON / 1 KIT in 1 BLISTER PACK
- 42192-623 - Levonorgestrel And Ethinyl Estradiol
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (42192-623). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 42192-623-28 identifies a specific commercial package of 1 blister pack in 1 carton / 1 kit in 1 blister pack of Levonorgestrel And Ethinyl Estradiol, a human prescription drug labeled by Acella Pharmaceuticals. This kit is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Acella Pharmaceuticals on August 21, 2023. The current certification is valid through December 31, 2026.
How is this Acella Pharmaceuticals product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 42192062328. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.